Blinded; Golimuma


Combined with:

Placebo

Indications and Reactions:

Role Indications Reactions
Primary
Colitis Ulcerative 66.2%
Rheumatoid Arthritis 16.1%
Unevaluable Event 3.6%
Prophylaxis 2.2%
Constipation 1.3%
Arthralgia 1.1%
Hypertension 1.1%
Nutritional Support 0.9%
Osteoporosis 0.9%
Abdominal Pain 0.8%
Pain 0.8%
Antibiotic Prophylaxis 0.6%
Cardiovascular Event Prophylaxis 0.6%
Product Used For Unknown Indication 0.6%
Sjogren's Syndrome 0.6%
Tachycardia 0.6%
Gastritis Prophylaxis 0.5%
Gastrointestinal Disorder Therapy 0.5%
Insomnia 0.5%
Mineral Supplementation 0.5%
Pneumonia 19.5%
Anal Abscess 8.6%
Septic Shock 7.0%
Colon Cancer 6.3%
Colitis 5.5%
Bone Neoplasm 3.9%
Breast Abscess 3.9%
Campylobacter Intestinal Infection 3.9%
Cellulitis 3.9%
Colitis Ulcerative 3.9%
Haematoma Infection 3.9%
Infection 3.9%
Pyrexia 3.9%
Urinary Tract Infection 3.9%
Chronic Obstructive Pulmonary Disease 3.1%
Cytomegalovirus Infection 3.1%
Enterocolitis Infectious 3.1%
Herpes Zoster 3.1%
Teratoma 3.1%
Abscess Intestinal 2.3%
Secondary
Colitis Ulcerative 50.4%
Rheumatoid Arthritis 25.2%
Prophylaxis 3.9%
Constipation 3.7%
Antibiotic Prophylaxis 1.7%
Abdominal Pain 1.6%
Conjunctival Hyperaemia 1.5%
Sleep Disorder 1.5%
Unevaluable Event 1.5%
Sjogren's Syndrome 1.5%
Gastritis Prophylaxis 1.2%
Hypertension 1.2%
Drug Exposure During Pregnancy 1.0%
Cellulitis 0.8%
Reflux Laryngitis 0.8%
Arthralgia 0.5%
Nutritional Support 0.5%
Vitamin Supplementation 0.5%
Osteoporosis 0.4%
Asthma 0.4%
Pneumonia 13.2%
Encephalitis 11.4%
Bone Neoplasm 10.5%
Septic Shock 8.1%
Rheumatoid Arthritis 7.8%
Meningitis Viral 6.3%
Gastroenteritis Rotavirus 6.0%
Cellulitis 5.7%
Anal Abscess 5.1%
Urinary Tract Infection 3.6%
Teratoma 3.0%
Breast Abscess 2.7%
Colitis Ulcerative 2.4%
Colon Cancer 2.4%
Breast Cancer 2.1%
Colitis 2.1%
Herpes Zoster 2.1%
Victim Of Crime 2.1%
Campylobacter Intestinal Infection 1.8%
Intra-uterine Death 1.8%

Drug Data